August 20, 2024

neffy® nasal spray– emergency epi without a needle

Send us Fan Mail Summary: neffy® nasal spray received fast track approval from the FDA on August 9, 2024 for the emergency treatment of type I allergic reactions, including anaphylaxis, in adult and pediatric patients who weight at least 66 pounds. This may be a gamechanger in that it provides emergency epinephrine treatment for anaphylaxis without needles. But, as with all medications, correct use and monitoring is necessary. Topics · ...

Also available on Apple Podcasts ↗